Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-085342

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David W. Oldach
Officer — Chief Medical Officer
Period of report
Dec 11, 2015
Accepted (ET)
Dec 15, 2015 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 11, 2015M8,222$2.28A9,322D
Common StockDec 11, 2015S8,222$30.33D1,100D
Common StockDec 15, 2015M1,778$2.28A2,878D
Common StockDec 15, 2015S1,778$30.00D1,100D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F7$2.28Dec 11, 2015M8,222D—Feb 28, 2021Common Stock8,22218,125D
Employee Stock Option (Right to Buy)F7$2.28Dec 15, 2015M1,778D—Feb 28, 2021Common Stock1,77816,347D
Employee Stock Option (Right to Buy)F2$23.51holding————Dec 31, 2024Common Stock23,00023,000D
Employee Stock Option (Right to Buy)F3$13.10holding————Jan 7, 2024Common Stock7,5007,500D
Employee Stock Option (Right to Buy)F4$6.64holding————Mar 6, 2023Common Stock10,00010,000D
Employee Stock Option (Right to Buy)F5$6.63holding————Jan 17, 2023Common Stock14,08714,087D
Employee Stock Option (Right to Buy)F6$7.47holding————Mar 20, 2022Common Stock20,00020,000D

Explanation of responses